Manual der Arbeitsgruppe Interventionelle Kardiologie (AGIK) der Deutschen Gesellschaft für Kardiologie – Herz- und Kreislaufforschung e.V. (DGK)

Nef, Holger; Achenbach, Stephan; Birkemeyer, Ralf; Dörr, Oliver; Elsässer, Albrecht; Gaede, Luise; Gori, Tommaso; Hoffmeister, Hans Martin; Hofmann, Felix J.; Katus, Hugo A.; Liebetrau, Christoph; Maßberg, Steffen; Pauschinger, Matthias; Schmitz, Thomas; Süselbeck, Tim; Voelker, Wolfram; Wiebe, Jens; Zahn, Ralf; Hamm, Christian W.; Zeiher, Andreas M.; Möllmann, Helge

doi:10.1007/s12181-021-00504-6

Cited by 4 publications

(2 citation statements)

References 195 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Non-specific complications such as allergic reaction, access-site complications, kidney injury, and infections do not exceed 1% in the literature. 69 …”

Section: Complications and Their Managementmentioning

confidence: 99%

Balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension: a clinical consensus statement of the ESC working group on pulmonary circulation and right ventricular function

Lang,

Andreassen,

Andersen

et al. 2023

European Heart Journal

View full text Add to dashboard Cite

The current treatment algorithm for chronic thromboembolic pulmonary hypertension (CTEPH) as depicted in the 2022 European Society of Cardiology (ESC)/European Respiratory Society (ERS) guidelines on the diagnosis and treatment of pulmonary hypertension (PH) includes a multimodal approach of combinations of pulmonary endarterectomy (PEA), balloon pulmonary angioplasty (BPA) and medical therapies to target major vessel pulmonary vascular lesions, and microvasculopathy. Today, BPA of >1700 patients has been reported in the literature from centers in Asia, the US, and also Europe; many more patients have been treated outside literature reports. As BPA becomes part of routine care of patients with CTEPH, benchmarks for safe and effective care delivery become increasingly important. In light of this development, the ESC Working Group on Pulmonary Circulation and Right Ventricular Function has decided to publish a document that helps standardize BPA to meet the need of uniformity in patient selection, procedural planning, technical approach, materials and devices, treatment goals, complications including their management, and patient follow-up, thus complementing the guidelines. Delphi methodology was utilized for statements that were not evidence based. First, an anatomical nomenclature and a description of vascular lesions are provided. Second, treatment goals and definitions of complete BPA are outlined. Third, definitions of complications are presented which may be the basis for a standardized reporting in studies involving BPA. The document is intended to serve as a companion to the official ESC/ERS guidelines.

show abstract

“…Non-specific complications such as allergic reaction, access-site complications, kidney injury, and infections do not exceed 1% in the literature. 69 …”

Section: Complications and Their Managementmentioning

confidence: 99%

Balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension: a clinical consensus statement of the ESC working group on pulmonary circulation and right ventricular function

Lang,

Andreassen,

Andersen

et al. 2023

European Heart Journal

View full text Add to dashboard Cite

show abstract

“…BPA is a percutaneous transcatheter technique utilizing the same equipment as percutaneous coronary intervention (PCI) [34]. However, the principle of BPA is different from that of coronary intervention.…”

Section: Principles Of Balloon Pulmonary Angioplastymentioning

confidence: 99%

Update on balloon pulmonary angioplasty for treatment of chronic thromboembolic pulmonary hypertension

Lang¹

2022

Current Opinion in Pulmonary Medicine

View full text Add to dashboard Cite

Purpose of reviewTo provide an update on balloon pulmonary angioplasty (BPA) for the treatment of chronic thromboembolic pulmonary hypertension (CTEPH), a pulmonary vascular disease that is characterized by fibro-thrombotic material mechanically obliterating major pulmonary arteries, resulting in increased pulmonary vascular resistance (PVR), progressive pulmonary hypertension (PH) combined with a microscopic pulmonary vasculopathy [1▪▪], right ventricular (RV) failure [2] and premature death.Recent findingsData from a most recent CTEPH European registry (2015 and 2016) suggest significantly improved survival [3▪] of CTEPH patients compared with survival in the eighties [4], or with data from 2007 and 2009 [5]. Pulmonary endarterectomy (PEA) is still the gold-standard therapy for CTEPH [6,7]. However, only around two thirds of all CTEPH patients are amenable to surgery [3▪,5]. Patients not suitable for PEA and treated conservatively have a poor prognosis [8]. BPA may have a role for this particular group of patients. [9–11]. Currently, BPA programs are available in many countries, with excellent results at expert centers [12–15,16▪,17,18▪▪]. Based on recent data, BPA seems to have a greater impact on symptomatic and hemodynamic improvement than medical therapy with riociguat alone [15].SummaryThe evidence favoring BPA is growing, but there is still a lack of published controlled trials. In addition, treatment concepts including indication, technical performance, use of PH-targeted medication, and the concept of follow-up vary between centers. In addition, there is a significant learning curve impacting outcomes [13]. The data from the International BPA registry will provide answers for some of the open questions.

show abstract

Hauptstammintervention – Ist ein Stent doch besser als zwei?

Dörr

2022

Herz

View full text Add to dashboard Cite

Manual der Arbeitsgruppe Interventionelle Kardiologie (AGIK) der Deutschen Gesellschaft für Kardiologie – Herz- und Kreislaufforschung e.V. (DGK)

Cited by 4 publications

References 195 publications

Balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension: a clinical consensus statement of the ESC working group on pulmonary circulation and right ventricular function

Balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension: a clinical consensus statement of the ESC working group on pulmonary circulation and right ventricular function

Update on balloon pulmonary angioplasty for treatment of chronic thromboembolic pulmonary hypertension

Hauptstammintervention – Ist ein Stent doch besser als zwei?

Contact Info

Product

Resources

About